8.14
price down icon9.56%   -0.86
after-market After Hours: 8.34 0.20 +2.46%
loading

Recursion Pharmaceuticals Inc Stock (RXRX) Latest News

pulisher
08:41 AM

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? - MSN

08:41 AM
pulisher
03:47 AM

Top Biotech Stocks To ConsiderFebruary 20th - MarketBeat

03:47 AM
pulisher
Feb 24, 2025

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL

Feb 24, 2025
pulisher
Feb 24, 2025

Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th - The Manila Times

Feb 24, 2025
pulisher
Feb 23, 2025

Recursion Pharmaceuticals, Inc. (RXRX): The Best Performing Pharma Stock So Far in 2025? - Insider Monkey

Feb 23, 2025
pulisher
Feb 23, 2025

(RXRX) Trading Signals - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 22, 2025

10 Best Performing Pharma Stocks So Far in 2025 - Insider Monkey

Feb 22, 2025
pulisher
Feb 21, 2025

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite? - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Cathie Wood Explains Why She Likes Recursion Pharmaceuticals, Inc. (RXRX) - MSN

Feb 21, 2025
pulisher
Feb 20, 2025

Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult - Dealbreaker

Feb 20, 2025
pulisher
Feb 20, 2025

Biotech Stocks Worth WatchingFebruary 15th - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) is the Best Performing Healthcare Stock So Far in 2025 - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts - MM+M Online

Feb 19, 2025
pulisher
Feb 19, 2025

10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey

Feb 19, 2025
pulisher
Feb 19, 2025

Recursion CEO launches pre-seed fund in response to NIH cuts - BioPharma Dive

Feb 19, 2025
pulisher
Feb 19, 2025

Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc. (RXRX) - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Can This New Biotech Fund Save 1,500 Startups Hit by SBIR Changes? - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

Could this Nvidia-backed growth stock be a millionaire-maker at $10? - Yahoo Finance UK

Feb 19, 2025
pulisher
Feb 19, 2025

Recursion CEO: Publicly funded research built the biopharma industry. Now it needs our help - STAT

Feb 19, 2025
pulisher
Feb 18, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

5 Stocks Jensen Huang’s Company is Betting On - Insider Monkey

Feb 18, 2025
pulisher
Feb 18, 2025

Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Altitude Lab's Startup Portfolio Hits $154M Milestone: Inside the Biotech Incubator's Success Story - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

25 Top AI Stocks That Could Boost Your Portfolio - The Motley Fool

Feb 18, 2025
pulisher
Feb 18, 2025

SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge - NewsBreak

Feb 18, 2025
pulisher
Feb 17, 2025

Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Best Biotech Stocks To Keep An Eye OnFebruary 14th - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Promising Mid Cap Stocks To Add to Your WatchlistFebruary 16th - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move - RagingBull

Feb 17, 2025
pulisher
Feb 17, 2025

Promising Biotech Stocks To Follow NowFebruary 17th - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) Soared Last Week - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals (NASDAQ: RXRX) Surges Nearly 24% as Nvidia Retains Stake – market - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals Stock Soars as Nvidia Maintains Stake – A Vote of Confidence? – market - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals (RXRX) Sees Institutional Investors Adjust Positions Amid Market Volatility - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Institutional Investors Bet Big on Recursion Pharmaceuticals (RXRX) Amid Growing Biotech Interest - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Why Recursion Pharmaceuticals (RXRX) Skyrocketed 23.88% on Friday – market - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals (RXRX): A Biotech Stock Outpacing the Market with Explosive Growth - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals (RXRX) Stock Surges 15%: Nvidia’s Vote of Confidence Sparks AI Biotech Rally - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Recursion Pharmaceuticals Stock Surges 15.8% as Nvidia Retains Stake – market - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

Mirae Asset Global Investments Co. Ltd. Sells 74,818 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Shares of 10 Firms Soar on Friday - Insider Monkey

Feb 15, 2025
pulisher
Feb 15, 2025

Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday? - Insider Monkey

Feb 15, 2025
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):